Literature DB >> 19166162

Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.

H Sorkhi1, M R H Roushan, G H Al Hashemi, M R E Dooki, S Bai.   

Abstract

The aim of this study was to determine the efficacy of hepatitis B virus (HBV) vaccination and the response to vaccine in individuals on haemodialysis with and without HCV infection. From April 2000 to September 2003 all haemodialysis patients referred to the haemodialysis department in a Babol hospital received 4 microg vaccine intramuscularly at 0, 1, and 6 months. All were negative for HBV infection markers (HBcAb, HBsAg and HBsAb). Of 62 patients, 53 (85.5%) responded to vaccination and 26 (49.1%) were high responders. All individuals with HCV infection responded to vaccination. Duration of haemodialysis had no effect on response to vaccination.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19166162

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN： 1020-3397            Impact factor:   1.628


  6 in total

1.  Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kullaya Takkavatakarn; Kearkiat Praditpornsilpa; Claudia Nader; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  J Nephrol       Date:  2019-11-07       Impact factor: 3.902

2.  Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers.

Authors:  Halil İbrahim Erdoğdu; Eray Atalay; Gül Gürsoy; Başol Canbakan; Serkan Aktürk; Canan Yazıcı; Orhan Yücel; Sinan Mersin; Sengül Üçer; Özgür Merhametsiz; Can Öner; Merve Erat
Journal:  Clin Exp Nephrol       Date:  2018-11-28       Impact factor: 2.801

3.  The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy.

Authors:  Jaswinder Singh Sodhi; Wasim Raja; Showkat Ali Zargar; Abid Showkat; Shaheena Parveen; Syed Nisar; Manzoor Ahmad Wani; Gul Javid; Mushtaq Khan; Sheikh Aejaz; Gul Mohd; Aleem Jan; Gh Nabi Yattoo; Altaf Shah; Gh Mohd Gulzar; Rashid Lone
Journal:  Indian J Gastroenterol       Date:  2015-11-04

4.  Improving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvants.

Authors:  Mohammad Hossein Somi; Babak Hajipour
Journal:  ISRN Gastroenterol       Date:  2012-09-18

5.  Serum anti-hepatitis B surface antigen in hemodialysis patients.

Authors:  Mahmoud Rafieian-Kopaei; Hamid Nasri
Journal:  J Nephropharmacol       Date:  2012-01-04

6.  Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients.

Authors:  Alicja E Grzegorzewska; Piotr M Wobszal; Adrianna Mostowska; Paweł P Jagodziński
Journal:  BMC Nephrol       Date:  2012-08-03       Impact factor: 2.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.